What Is the Market Sentiment on CTVA?

Corteva stock is trading -12.61% below its average target price of $61.52 after dropping -4.8% during today's afternoon session. Analysts are giving the Large-Cap Farming company an average rating of buy and target prices ranging from $53.0 to $67.0 per share.

The stock has a very low short interest at 1.5%, and a short ratio of 2.57. At 0.09%, the company's rate of insider ownership does not indicate that management is heavily invested in the corporation. Finally, we also note that a significant number of institutional investors are invested in the stock, with 82.6% of Corteva's shares being owned by this investor type.

Institutions Invested in Corteva

Date Reported Holder Percentage Shares Value
2023-12-31 Vanguard Group Inc 12% 80,340,862 $4,319,124,606
2023-12-31 Blackrock Inc. 8% 53,895,841 $2,897,440,321
2023-12-31 State Street Corporation 5% 32,556,141 $1,750,218,085
2023-12-31 Capital International Investors 4% 25,758,735 $1,384,789,550
2023-12-31 Aristotle Capital Management, LLC 4% 25,343,464 $1,362,464,582
2023-12-31 Geode Capital Management, LLC 2% 15,455,976 $830,913,243
2023-12-31 Massachusetts Financial Services Co. 2% 13,236,504 $711,594,432
2023-12-31 Northern Trust Corporation 2% 12,815,795 $688,977,117
2023-12-31 Nuveen Asset Management, LLC 2% 12,704,984 $683,019,918
2023-12-31 Independent Franchise Partners, LLP 2% 12,289,093 $660,661,619

Besides an analyst consensus of some upside potential, other market factors point to there being mixed market sentiment on Corteva.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.